Analysis of Suicide Risk in Patients with Penile Cancer and Review of the Literature
- 1. Department of Urology, Medical College of Georgia at Augusta University, USA
- 2. Department of Urology, University of Toronto, Canada
- 3. Department of Urology, University of Michigan, USA
Absract
Introduction: The treatment for penile cancer has been shown to cause harmful psychiatric symptoms as well as have detrimental effects on well-being. In the past several years, alternatives to total or partial penectomy have emerged, such as chemotherapy, radiation, penile sparing, and laser ablation therapies. Since we have published on this topic in general, a more specific breakdown for penile cancer is in order as the therapy has the potential for life changing surgery.
Materials and methods: We examined the SEER (1973-2013) database, comprising of 28% of the U.S. population. ICD-10 codes C60.8-C60.9 and the ICD-O codes 8010/2, 8010/3, 8051/2, 8051/3, 8052/2, 8052/3, 8070/2, 8070/3- 8072/3, 8074/3, 8076/3, and 8083/3-8084/3 were used. Age, race, marital status, and psychological variables were studied. We used contingency tables of suicide rates; mid-P exact test was used for analysis.
Results: There were 13 suicides were noted in 6,155 patients with squamous cell carcinoma of the penis. All patients that committed suicide had undergone a surgical intervention.
Conclusion: There is no doubt that penile cancer after treatment has a powerful effect on quality of life as increased depression and sexual anxiety have been continuously documented in post-op patients. This is in stark contrast to the observed suicide rate. Despite the reported negative psychologic effects in patients with penile cancer, suicide rates are amongst the lowest of all urologic malignancies.
Citation
Simpson WG, Klaassen Z, Jen RP, Neal DE, Terris MK (2017) Analysis of Suicide Risk in Patients with Penile Cancer and Review of the Literature. J Urol Res 4(1): 1077
ABBREVIATIONS
HRQOL: Health Related Quality of Life, OR: Odds Ratio, SCC: Squamous Cell Carcinoma
INTRODUCTION
Penile cancer is one of the more uncommon urologic cancers. The incidence in Europe and the US is close to 1 in 100,000 men [1,2], while it represents 10-20% of malignancy in men in Africa, Asian, and South America [3]. Squamous cell carcinoma (SCC) makes up> 95% of penile cancers with the most common risk factors being HPV-16, HPV-18, phimosis, smoking, and lower socio-economic status [2,4]. The average age of diagnosis is 60 years and the malignancy is more likely to be seen in men that are not married (OR 2.5) [1,5]. The impact of penile cancer has been shown to cause significant psychological/psychiatric impact.
The treatment for penile cancer varies significantly depending on cancer stage and has been shown to cause harmful psychiatric symptoms in approximately 50% of patients as well as have detrimental effects on well-being in up to 40% of patients [2]. More aggressive treatments such as a partial penectomy have been shown to cause anxiety in 31-58% of patients and depression in 39% of patients [6,7] with significantly higher rates of anxiety in patients treated with a total penectomy [8]. Much of these psychological/psychiatric effects are thought to be secondary to the devastating effect on a man’s self-image and sexual function [7,9]. For that reason, modalities such as penile sparing surgical approaches, chemotherapy/radiation protocols, and laser ablative surgeries have been investigated as options to sexuality and HRQOL [9-11].
Approximately 70% of suicides in the elderly (> 60 years-old) are attributed to physical illness and malignancy [12]. We sought to investigate the risk of suicide in patients with penile cancer.
MATERIALS AND METHODS
Data sources
Patients with penile cancer were identified from the Surveillance, Epidemiology, and End Results (SEER) database. The SEER database reports cancer-specific outcomes from specific geographic areas representing 28% of the US population [13]. The study cohort consisted of patients from all 18 registries comprising SEER from 1973 through 2013. Comparisons with the general US population were based on data from the Centers for Disease Control and Prevention’s National Center for Injury Prevention and Control (1999-2010) [14].
Study population
Patients were identified in the SEER database using the primary site code C60.8-C60.9 for penile cancer. To increase generalizability, squamous cell carcinoma histology for penile cancer was identified using International Classification of Diseases for Oncology (ICD-O) codes, specifically ICD-O codes 8010/2, 8010/3, 8051/2, 8051/3, 8052/2, 8052/3, 8070/2, 8070/3-8072/3, 8074/3, 8076/3, and 8083/3-8084/3.
Description of variables
Demographic variables of interest included age at the time of diagnosis (by decade), race (African American vs white vs other), and marital status (married vs single/divorced/widowed [SDW]). Clinical and pathologic variables included disease SEER histologic grade, and SEER stage (localized vs regional vs distant vs unstaged). Previous studies have determined important psychosocial/environmental risk factors for suicide, including but not limited to heavy alcohol and drug use, perceived sadness/hopelessness, low academic achievement, poor perceived health status, and high perceived stress [15]. Given the variables available in the SEER database, only the aforementioned demographic, clinical, and pathologic variables were used for the current analysis. The primary outcome was suicide (yes/no). Patients were considered to have committed suicide as previously described [16]. Overall survival was calculated for those dead of suicide (DOS) and those dead of causes other than suicide (DOC). Contingency tables of suicide rates were calculated as previously described [3]. Standardized mortality ratios (SMRs) and 95% confidence intervals (95% CIs) were calculated using the mid-P exact test as previously described [17]. Briefly, suicide rates (number of suicides divided by person-years of survival) were calculated to allow comparison between the anatomic cancer site and the general population [14,16]. Calculated SMRs for the US population based on age ranges 58-77 years) [14].
RESULTS
There were suicides identified among 1,239,522 individuals with genitourinary malignancies observed for 7,307,377 personyears. There were 13 suicides out of 6,155 patients with penile cancer (SMR, 1.58; 95% CI, 1.18-2.11) (Table 1). Of the 6,155 patients with penile cancer, 5,569 underwent surgical treatment for their disease. 593 patients chose to undergo adjuvant or solitary radiation therapy. All 13 suicides recorded were amongst those who had undergone a surgical intervention (partial penectomy, total penectomy, etc) and 1 who had undergone adjuvant radiation. The median overall survival for penile cancer for DOS was 37 months and for DOC was 25 months. All patients who committed suicide were between the ages of 50-79 years of age. 11 patients were married while 2 were SDW.
As with other malignancies, there was an increased risk of suicide in white patients and with advancing age with penile cancer (Table 1). Unlike other malignancies in which suicide risk is greater in advanced stage and grade and in single/divorced/ widowed patients, penile cancer demonstrated an inverse association with cancer stage/grade (Table 2) and marital status (Table 1).
Table 1: Incidence of Suicide Among Patients with Penile Cancer by Demographic Characteristics (1973-2013).
Factor | Persons | Number of Suicides |
Person-Years | Suicide Rates per 100,000 PersonYears |
SMR | 95% CI |
Population | 6,155 | 13 | 34,197 | 38 | 1.58 | 1.18-2.11 |
≤ 39 | 248 | 0 | 2,067 | 0 | - | - |
40-49 | 558 | 0 | 4,745 | 0 | - | - |
50-59 | 1,020 | 5 | 7,409 | 67 | 2.56 | 2.04-3.19 |
60-69 | 1,575 | 5 | 9,138 | 55 | 2.43 | 1.88-3.08 |
70-79 | 1,602 | 3 | 7,620 | 39 | 1.39 | 1.04-1.84 |
≥ 80 | 1,152 | 0 | 3,218 | 0 | - | - |
Marital Status | ||||||
Married | 3,556 | 11 | 22,269 | 49 | 2.05 | 1.57-2.64 |
SDW | 2,154 | 2 | 9,712 | 21 | 0.84 | 0.56-1.21 |
Unknown | 445 | 0 | 2,216 | 0 | - | - |
Race | ||||||
African American | 607 | 0 | 3,114 | 0 | - | - |
Caucasian | 5,221 | 13 | 29,270 | 44 | 1.67 | 1.26-2.17 |
Other | 270 | 0 | 1,490 | 0 | - | - |
Unknown | 57 | 0 | 322 | 0 | - | - |
Abbreviations: 95% CI, 95% confidence interval; SDW, single/divorced/widowed; SMR, standardized mortality ratio. | ||||||
a Compared with suicide rates of the general US population according to the Centers for Disease Control and Prevention’s Web-based Injury Statistics Query and Reporting System (WISQARS) (1999-2010). |
DISCUSSION AND CONCLUSION
Although more prevalent in underdeveloped countries, penile cancer is a rare urologic disease in the US and European countries. Analysis of the SEER database from 1998-2003 found 4967 cases of penile cancer with an incidence of 0.81 per 100,000 white males and 0.82 per 100,000 African American males.11Surgical treatment of penile cancer causes harmful psychiatric symptoms in approximately 50% of patients as well as have detrimental effects on well-being in up to 40% of patients.2 Varying treatment modalities affected sexual health, assessed most commonly by the IIEF-15, differently and are associated with different degrees of psychological impact (Table 3).
Both penile sparing and laser ablative therapies with the YAG laser are associated with fewer psychiatric effects. This is likely due to the fact that patients undergoing penile sparing surgery recover similar sexual function (as high as 72%) and have a satisfactory HRQOL [10,11]. Kieffer et al., found that patients who underwent penile sparing (n=54) there were few differences in HRQOL compared to the normative population and they also suffered from less problems with life interference and body image when compare to patient who underwent a partial penectomy [9]. Therapies such as the YAG laser (combined carbon dioxide and neodymium) can be considered in patient with Tis-T2, GI-II tumors less than 3cm (95% cancer specific survival at 5 yrs) with low recurrence rates (19%) [14].
Partial penectomy, commonly reserved for tumors confined to the glands or distal shaft, has been shown in the literature to have mixed psychiatric/psychologic effects. Many articles, using the IIEF-15, have reported significant impairment in erectile function, orgasmic function, sexual desire, intercourse satisfaction, overall sexual satisfaction, and body image [6-8,18]. Yu et al., conducted a prospective study of 43 men with penile cancer undergoing partial penectomy in 2015; they assessed preand post-operative sexual health using the IIEF-15 and found there to be a significant difference in each domain of the survey. Furthermore, patients undergoing partial penectomy were found to higher levels of anxiety and depression (as high as 58% and 39% respectively) [6,8,18]. Individuals with proximally invasive penile cancer requiring a total penectomy have significantly higher anxiety levels compared to those undergoing a partial penectomy [8].
Malignancy has been shown to be a significant cause of suicide in those greater than 60 years old. Our prior analysis of the SEER database from 1973-2013, we found 2276 suicides in patients with urologic cancer (Prostate cancer: 1613, Bladder cancer: 439, Kidney cancer: 140, Testis cancer: 71, Penile cancer: 13). Despite all the detrimental psychological effects that treatments for penile cancer have, only 13 of the 2276 patients that committed suicide had penile cancer. The current analysis shows that those patients committing suicide with penile cancer also do not follow trends observed for other malignancies, particularly the fact that penile cancer patients with low grade and stage were more likely to commit suicide. This fact contradicts many of the studies in the literature reporting improved HRQOL with lower grade and stage tumors treated conservatively (Table 3).
Although the literature reports mixed effects on men’s HRQOL and sexual health, the overwhelming majority of articles analyzing those who underwent partial or total penectomy reported significant increases in anxiety and depression and significant decreases in sexual health. This topic has been investigated more thoroughly in penile cancer than any other urologic cancer. In our retrospective analysis, all 13 patients had undergone some form of surgical intervention of unknown approach. However,
despite all the detrimental effects reported, penile cancer has not been shown to cause increased risk for suicide compared to other urologic malignancies. One explanation for this may be the fact that penile cancer is so rare and therefore more retrospective studies of large databases should be carried out.
Table 2: Incidence of Suicide Among Patients With Penile Cancer by Clinicopathologic Characteristics
Factor | Persons | Number of Suicides |
Person-Years | Suicide Rates per 100,000 PersonYears |
SMR | 95% CI |
Grade | ||||||
Well differentiated; Grade I |
1,609 | 4 | 10,708 | 37 | 1.55 | 1.15- 2.07 |
Moderately differentiated; Grade II |
2,163 | 3 | 10,438 | 29 | 1.17 | 0.82-1.60 |
Poorly differentiated; Grade III |
1,011 | 2 | 4,002 | 50 | 2.01 | 1.53-2.56 |
Undifferentiated; Anaplastic; Grade IV |
43 | 0 | 209 | 0 | - | - |
Unknown | 1,329 | 4 | 8,840 | 45 | 1.84 | 1.41-2.41 |
Stage | ||||||
Localized | 3,774 | 10 | 24,186 | 41 | 1.71 | 1.29-2.26 |
Regional | 1,771 | 3 | 3,494 | 86 | 3.42 | 2.78-4.14 |
Distant | 295 | 0 | 452 | 0 | - | - |
Unstaged | 315 | 0 | 1,566 | 0 | - | - |
Surgery Performed | ||||||
Yes | 5,569 | 13 | 32,167 | 40 | 1.62 | 1.22-2.14 |
No | 535 | 0 | 1,789 | 0 | - | - |
Unknown | 51 | 0 | 241 | 0 | - | - |
Radiation Performed | ||||||
Yes | 593 | 1 | 2,76 | 36 | 1.5 | 1.11-2.02 |
No | 5,481 | 12 | 31,121 | 39 | 1.57 | 1.16-2.08 |
Unknown | 81 | 0 | 314 | 0 | - | - |
Abbreviations: 95% CI, 95% confidence interval; RPLND, retroperitoneal lymph node dissection; SMR, standardized mortality ratio. | ||||||
a Compared with suicide rates of the general US population according to the Centers for Disease Control and Prevention’s Web-based Injury Statistics Query and Reporting System (WISQARS) (1999-2010). |
Table 3: Studies reviewed for psychological/psychiatric effects of penile cancer.
Author | Sample Size |
Mean Age | Design | Intervention | Parametric Tool | Findings |
Yu et al ., 20166 | 43 | 56 | Prospective | Partial Pen (n= 43) | IIEF-15 SAS SDS |
Pre and Postop IIEF-15 scores were significantly different in each domain. Postop Anxiety and depression seen in 58% and 39% respectively |
Kieffer et al ., 20149 | 90 | 65.4 | Retrospective | Penile sparing (n=54) Partial Pen (n=36) | SF-36 IIEF-15 IOC (version 2) |
Few differences were observed in sexuality or health related QOL compared to normative population. Partial Pen associated with more problems with life interference and body image |
Novac et al ., 20138 | 11 | 62.9 | Retrospective | Total Pen (n=2) Partial Pen (n=6) Biopsy (n=3) |
HAM-A HAM-D |
Moderate-Severe depression in both partial and total penectomy groups. Sig higher Anxiety in total penectomy compared to partial (p=0.02) |
Gulino et al ., 200710 | 14 | 54 | Prospective | Penile sparing (n=14) | IIEF-15 Bigelow & Young |
Recovery of similar sexual function compared to preop. Satisfactory QoL |
Romero et al ., 20057 |
18 | 52 | Retrospective | Partial Pen (n= 18) | IIEF-15 | Erectile function, orgasmic function, sexual desire, intercourse satisfaction, overall sexual satisfaction were significantly reduced |
Windahl et al ., 200411 |
40 | 64 | Retrospective | YAG laser ablation (n=40) | IIEF-11 LiSat-11 Self made sexual function Self made sexual activity |
Sexual function and satisfaction only marginally reduced compared to preop. 72% with sex life as good as they wanted, |
Ficarra et al ., 200018 |
16 | n/a | Retrospective | Partial Pen (n=14) | HADS GHQ | Significant impairment of the general state of health and higher levels of anxiety compared to control |
Abbreviations: GHQ: General Health Questionnaire; HAM-A: Hamilton Anxiety Rating Scale, HAM-D: Hamilton Rating Scale for Depression; IOC: Impact of Cancer (Version 2); IIEF-15: International Index of Erectile Function; LiSat-11: Life Satisfaction in 18- to 64-year-old Swedes; SAS: SelfRating Anxiety Scale; SDS: Self-Rating Depression Scale; SF-36: Short Form -36 Health Survey |